Comparison of the effectiveness of combined treatment of topical L-carnitine lotion 1% with clotrimazole lotion 2% and clotrimazole lotion 2% alone in the treatment of seborrheic dermatitis of the head (scalp)

Comparison of the effectiveness of combined treatment of topical l-carnitine 1% and clotrimazole 2% with clotrimazole 2% alone, in patients with scalp seborrheic dermatitis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150706023081N4

Enrollment

Registered

2024-05-20

Start date

2024-06-21

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Seborrheic dermatitis. Other seborrheic dermatitis

Interventions

Intervention 1: Intervention group: Under the combined treatment of L-carnitine and clotrimazole, where the patient uses 1 cc of the solution twice a day in 4 areas, and the duration of the treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Having seborrheic dermatitis in the scalp area with clinical diagnosis No treatment with topical or systemic corticosteroids for the previous four weeks No treatment with methyldopa, chlorpromazine, local or systemic anti-acne drugs for one month before Absence of systemic diseases such as Parkinson's, AIDS and mood disorders

Exclusion criteria

Exclusion criteria: Pregnancy Lack of consent to continue participating in the study Breastfeeding

Design outcomes

Primary

Measure	Time frame
Scaling. Timepoint: At the beginning of study and 3 months later. Method of measurement: Dermoscopy.;Scalp erythema. Timepoint: At the beginning of study and 3 months later. Method of measurement: Dermoscopy.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFariba Iraji

Esfahan University of Medical Sciences

iraji@med.mui.ac.ir+98 31 3620 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026